RNA‐dependent RNA polymerase of SARS‐CoV‐2 as a therapeutic target-Reference-Cited by-同舟云学术

RNA‐dependent RNA polymerase of SARS‐CoV‐2 as a therapeutic target

Published:2020-07-19 Issue:1 Volume:93 Page:300-310
ISSN:0146-6615
Container-title:Journal of Medical Virology
language:en
Short-container-title:J Med Virol

Author:

Wang Yanyan¹,Anirudhan Varada²,Du Ruikun¹³⁴,Cui Qinghua¹³⁴^ORCID,Rong Lijun²

Affiliation:

1. College of Pharmacy Shandong University of Traditional Chinese Medicine Jinan China

2. Department of Microbiology and Immunology University of Illinois at Chicago Chicago Illinois

3. Shandong Provincial Collaborative Innovation Center for Antiviral Traditional Chinese Medicine Jinan China

4. Qingdao Academy of Chinese Medicinal Sciences Shandong University of Traditional Chinese Medicine Qingdao China

Funder

Natural Science Foundation of Shandong Province

Publisher

Wiley

Subject

Infectious Diseases,Virology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jmv.26264

Reference136 articles.

1. WHO.Coronavirus disease (COVID‐2019) situation reports.https://www.who.int/emergencies/diseases/novel-coronavirus-2019/situation-reports. Accessed June 23 2020.

2. Identification of a Novel Coronavirus in Patients with Severe Acute Respiratory Syndrome

3. Middle East Respiratory Syndrome Coronavirus: Another Zoonotic Betacoronavirus Causing SARS-Like Disease

4. Potential interventions for novel coronavirus in China: A systematic review

Cited by 82 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Favipiravir for COVID-19 in adults in the community in PRINCIPLE, an open-label, randomised, controlled, adaptive platform trial of short- and longer-term outcomes;Journal of Infection;2024-10

2. Amentoflavone from Selaginella tamariscina inhibits SARS-CoV-2 RNA-dependent RNA polymerase;Heliyon;2024-08

3. In silico antiviral properties of Spirulina platensis phycobiliprotein and phycobilin as natural inhibitor for SARS-CoV-2;Algal Research;2024-04

4. Recent advancements in the discovery of small-molecule non-nucleoside inhibitors targeting SARS-CoV-2 RdRp;Biomedicine & Pharmacotherapy;2024-02

5. Drug repurposing screens identify Tubercidin as a potent antiviral agent against porcine nidovirus infections;Virus Research;2024-01